Wearable Monitoring Device in Daily Lives of Community-dwelling Older

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04759066` - The HEALiX™ Intubated Patient (IP) Pilot Study	N/A
Completed	`NCT01948375` - A Crossover Study on the Blinding Effect of a New Pragmatic Placebo Needle	N/A
Not yet recruiting	`NCT05180552` - The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting	N/A

See also

Status

Clinical Trial

Phase

Withdrawn

NCT04759066 - The HEALiX™ Intubated Patient (IP) Pilot Study

N/A

Completed

NCT01948375 - A Crossover Study on the Blinding Effect of a New Pragmatic Placebo Needle

N/A

Not yet recruiting

NCT05180552 - The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05269303
Study type	Interventional
Source	The Hong Kong Polytechnic University
Contact
Status	Completed
Phase	N/A
Start date	July 10, 2022
Completion date	July 9, 2023

Wearable Monitoring Device in Daily Lives of Community-dwelling Older Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms